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Background. Older individuals represent a substantial proportion of international travelers. Because of physiological changes and
the increased probability of underlying medical conditions, older travelers might be at higher risk for at least some travel-associated
diseases.
Methods. With the aim of describing the epidemiology of travel-associated diseases in older adults, medical data were prospectively
collected on ill international travelers presenting to GeoSentinel sites from 1997 to 2009. Seven thousand thirty-four patients
aged 60 years and over were identified as older travelers and were compared to 56,042 patients aged 18–45 years, who were used
as the young adult reference population.
Results. The proportionate morbidity of several etiological diagnoses was higher in older ill travelers compared to younger
ill, including notably lower respiratory tract infections, high-altitude pulmonary edema, phlebitis and pulmonary embolism,
arthropod bites, severe malaria, rickettsiosis, gastritis, peptic ulcers, esophagitis and gastroesophageal reflux disease, trauma and
injuries, urinary tract infections, heart disease, and death. In contrast, acute diarrhea, upper respiratory tract infections, flu and
flu-like illnesses, malaria, dengue, genital infections, sexually transmitted diseases, and schistosomiasis proportionate morbidities
were lower among the older group.
Conclusion. Older ill travelers aremore likely to suffer from certain life-threatening diseases and would benefit from reinforcement
of specific preventive measures including use of anti-thrombosis compression stockings and sufficient hydration and exercises
during long-distance flights, hand hygiene, use of disposable handkerchiefs, consideration of face-masks in crowded conditions,
influenza and pneumococcal vaccines, progressive acclimatization to altitude, consideration of acetazolamide, and use of repellents
and mosquito nets. Antibiotics for the presumptive treatment of respiratory and urinary tract infections may be considered, as
well as antacid medications. At-risk patients should be referred to a specialist for medical evaluation before departing, and optimal
control of co-morbidities such as cardiovascular and chronic obstructive pulmonary diseases should be achieved, particularly for
high-altitude travel.
Older individuals represent a substantial proportionof international travelers, with an estimated
15–30% of travelers being aged 60 years or older;1–3
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this proportion is increasing over time.4 In a
study of 1,416 US travelers attending a pre-travel
clinic, 48% were >50 years of age, one third were
>60 years, and almost 1.5% were >80 years of age.2
Because of their greater difficulty in acclimatizing
during travel, adjusting to extreme climatic conditions
(temperature, humidity, and altitude), their greater
predisposition for contracting certain diseases, their
increased probability of underlying medical conditions,
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waning immunity fromvaccines previously received, and
reduced responses to vaccines provided at pre-travel
consultations, including those against hepatitis A,
hepatitis B, and rabies,5 as well as ‘‘routine’’ vaccines
such as influenza6 and pneumococcal infections,7 older
travelers might be at a higher risk for at least some
travel-associated diseases.8,9 The premiums of travel
health insurance for people over 60 years of age are
often a lot higher than those for younger people because
of an increased proportion of claims, costly air medical
evacuations,10 and death abroad in the older group.11
However, the epidemiology of travel-associated diseases
in older adults, including chronic disease exacerbation,
is not well described with the exception of traveler’s
diarrhea and considerable health advice written for
older travelers is based on data taken from the entire
older (non-traveling) population.9 There are wide
physiological differences between younger and older
people,12 although the population of older travelers may
be somewhat distinct from the general older population,
as the truly frail elderly probably do not frequently
undertake international travel.
No study has been published that addresses the
spectrum of illnesses among older individuals trav-
eling to a broad range of destinations. In this
context, we analyzed diagnoses with demographic, clin-
ical, and travel-related predictors of disease among
older ill travelers who presented to GeoSentinel
clinics between 1997 and 2009, including a large
proportion of individuals returning from tropical
countries.
Patients and Methods
Data Source
Data were prospectively collected on patients pre-
senting to GeoSentinel sites from March 1997 to
August 2009. The GeoSentinel Surveillance Network
(http://www.istm.org/geosentinel/main.html) consists
of specialized travel/tropical medicine clinics on six
continents, where ill travelers are seen during or after
traveling to a wide range of countries and where infor-
mation on travelers is prospectively recorded using a
standardized format.13 To be eligible for inclusion in
the GeoSentinel database, patients must have crossed
an international border and sought medical advice at a
GeoSentinel clinic for a presumed travel-related illness
or have been diagnosed with a disease related to a travel
history by the physician. Data collected included: demo-
graphic information, travel data, reason for most recent
travel, inpatient or outpatient status, history of a pre-
travel clinic visit, and travel-related clinical findings.
Chronic conditions and co-morbidities are not docu-
mented in the GeoSentinel database. Reasons for travel
were classified as: tourism, business, research/education,
missionary/volunteer work, military, medical tourism,
or visiting friends and relatives. Patients whose reason
for travel was to immigrate were excluded. Individ-
ual countries visited were grouped into eight regions
(Table 1). The place of exposure was defined by the
clinician if he/she had confidence that the illness was
acquired in that place given the duration of the incuba-
tion period and/or known endemicity patterns or if the
region was the only one visited by the patient. Medi-
cal data included the final physician-assigned diagnoses
according to a standardized list of 556 possible etiologi-
cal diagnoses of diseases, including death that were also
categorized under 21 broad syndromes, as previously
described.13 When necessary, several final diagnoses
were assigned to one patient. The travel duration, a
proxy for duration of exposure, was measured as the
duration of the most recent travel. The time to presen-
tation was calculated as the time between the end of
travel and presentation at a GeoSentinel clinic. These
two variables were evaluated for travelers seen after
travel only.
Statistical Analysis
Patients aged 60 years and over were identified as older
travelers with an age limit based on that used by many
travel insurance providers to define an older person and
were compared to patients aged 18–45 years as a young
adult reference population. Patients aged 46–59 years
were not included so that the comparison group of adult
travelers would have the greatest probability of differing
from travelers >60 years, in term of physiological status
and behavior during travel. Age groups were defined
prior to the statistical analysis. Data were entered into
and managed in Microsoft Access (Microsoft Corp.,
Redmond, WA, USA). In our evaluation, proportionate
morbidity refers to the number of cases of a specific
diagnosis (or of a group of specific diagnoses within
a syndrome group) compared with all cases of ill
travelers (excluding cases with the specific diagnosis
being investigated) of the same age group that were
seen at GeoSentinel clinics during the same period.
Thus, the proportionate morbidity is not an acquisition
incidence rate of travel-related illness and cannot infer
absolute risk. Differences in the proportions (categorical
variables) were tested using Fisher exact tests, and
Kruskal–Wallis tests were used for continuous variables.
p Values <0.05 were considered significant. Odds ratios
(ORs) (older travelers vs young adult travelers) by
diagnosis were estimated by logistic regression and
adjusted for travel reason, sex, pre-travel advice, region
of exposure, and clinical setting. The Mantel–Haenszel
statistic was used to test for diagnosis trends by age
classes. All statistical tests were two-sided. Percentages
and ORs (with 95% confidence intervals), comparisons,
and graphic analyses were carried out using the R 2.8.1
environment (www.r-project.org).14
Results
A total of 89,521 ill travelers recorded in the
GeoSentinel database during the study period. A total
of 63,076 ill adult travelers were included in the
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Table 1 Demographic and travel data of 63,076 ill travelers seen in GeoSentinel clinics between 1997 and 2008
Age classes 18–45 y ≥60 y p-Value∗
Number of patients 56,042 7,034
Sex <0.001
Female 28,571 (51.0%) 3,174 (45.1%)
Male 27,180 (48.5%) 3,833 (54.5%)
Unknown 291 (0.5%) 27 (0.4%)
Region of residence (expatriates excluded) <0.001
Asia 3,850 (7.9%) 445 (6.7%)
Africa 469 (1.0%) 56 (0.8%)
Latin America 287 (0.6%) 38 (0.6%)
Europe (West and East) 24,391 (50.9%) 3,257 (49.1%)
Middle East 3,273 (6.8%) 215 (3.2%)
North America-Canada 12,885 (26.9%) 2,413 (36.4%)
Oceania 14 (0.0%) 2 (0.0%)
Australia-New Zealand 2,707 (5.6%) 209 (3.1%)
Reason for travel <0.001
Tourism 30,079 (53.7%) 4,666 (66.3%)
Business 13,119 (23.4%) 1,173 (16.7%)
Missionary/volunteer/research/aid work† 7,431 (13.3%) 599 (8.5%)
Visiting friends and relatives 3,902 (7.0%) 563 (8.0%)
Student‡ 1,306 (2.3%) 8 (0.1%)
Military 157 (0.3%) 8 (0.1%)
Medical tourism 48 (0.1%) 17 (0.2%)
Median travel duration [d (first to third quartiles)] 28 (14–86) 21 (14–42) <0.001
Risk level qualifier§<0.001
Expatriate 10,733 (19.2%) 782 (11.1%)
Pre-arranged or organized trip 7,289 (13.0%) 1,384 (19.7%)
Risk travel 13,437 (24.0%) 1,816 (25.8%)
Unknown 24,583 (43.9%) 3,052 (43.4%)
Pre-travel advice <0.001
Yes 28,999 (51.7%) 2,971 (42.2%)
No 16,834 (30.0%) 2,496 (35.5%)
Unknown 10,209 (18.2%) 1,567 (22.3%)
Clinical setting† <0.001
Seen after travel 36,936 (65.9%) 4,981 (70.8%)
Seen during travel 19,101 (34.1%) 2,053 (29.2%)
Unknown 5 (0.0%) –
Patient type 0.54
Outpatient 49,261 (87.9%) 6,177 (87.8%)
Inpatient 6,086 (10.9%) 782 (11.1%)
Unknown 695 (1.2%) 75 (1.1%)
Mean time to presentation (d) 13 15 <0.001
Region of travel <0.001
Asia 30,459 (54.4%) 3,311 (47.1%)
Africa 12,146 (21.7%) 1,543 (21.9%)
Latin America 8,761 (15.6%) 1,161 (16.5%)
Europe (West and East) 2,300 (4.1%) 542 (7.7%)
Middle East 796 (1.4%) 179 (2.5%)
North America-Canada 767 (1.4%) 171 (2.4%)
Oceania 440 (0.8%) 70 (1.0%)
Australia-New Zealand 373 (0.7%) 57 (0.8%)
Travel duration and time to presentation were calculated for travelers seen after travel only.
∗Unknown data were excluded from statistical analysis.
†Travel for missionary, volunteer, aid work, or research.
‡Travel to be a full-time student in a recognized educational institution or travel as part of a group trip under the sponsorship of a recognized educational institution, and
for which the primary purpose is study or a non-research educational activity. Not used for those traveling for other reasons who happen to be students.
§Expatriate—intended to identify individuals living in the destination country with an independent residence and address and using mostly the infrastructures used by
local residents of the same economic class. Independent of duration of residence. Expatriates in developing countries characterize those who eat mostly at home and
use their own transportation but will intermittently encounter risks (food, vectors, and sleeping conditions) faced by the local population. Pre-arranged and organized
trip—intended to identify travelers who are sheltered or ‘‘cocooned’’ from many of the risks (food, vectors, and sleeping conditions) faced by the local population, use the
infrastructure of the travel industry (including internet self-booking) in the home country for most of the arrangements, use standard or better hotel or other short-stay
temporary accommodations, eat mostly at restaurants that serve large numbers of foreigners and that are often pre-screened by tour operators or employers, and use
mostly in-country transportation specifically serving tourists or foreigners. Risk travel—intended to identify travelers who will, by their behavior, encounter a substantial
number of the risks facing the local population. This classification would generally include no pre-booking of accommodations for most or all nights and/or use of the
accommodations specific to budget travelers or those staying in the houses of local residents.
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study of which 7,034 were aged 60 years and over,
accounting for 8.4% of the whole population seen
at GeoSentinel clinics during the study period. The
mean age was 66 years in the older group (median:
65, range 60–98 y) and 31 years in the adult reference
group (median: 30, range 18–45 y). A total of 1,532
ill travelers were aged 70 years and over, accounting
for 22% of the older group. Demographic and travel
data showed several statistically significant differences
according to age (Table 1). Compared to younger
patients, older patients presenting to GeoSentinel sites
were more likely to be male, to be resident in North
America and Canada and to travel for tourism; there
were fewer business travelers in the older group.
The median travel duration was shorter in the older
traveler group. The proportion of individuals traveling
in pre-arranged or organized trips was higher among
older patients compared to younger patients, but the
proportion of those who had sought travel advice
was lower among the older group. The travel region
differed among age groups, with Europe, the Middle
East, and North America being more frequently visited
among older individuals. The proportionate morbidity
of broad syndromes also differed between older and
younger travelers (Table 2). Acute diarrhea was the
most common complaint in both groups of ill travelers,
although comparatively it was significantly less frequent
in the older group. While febrile systemic illness was the
second most common complaint in the younger group,
respiratory disease ranked as the second most frequent
reason for presentation to a GeoSentinel site in the
older group. Among other syndromes, non-diarrheal
gastrointestinal disease, musculoskeletal disorders,
neurological, genitourinary, and cardiovascular-related
morbidity were comparatively higher in the older group,
as were chronic diseases. Further analysis of diseases
in the older group showed that the proportionate
morbidity of some broad syndromes was higher in
patients traveling to specific regions, notably acute
diarrhea in Asia, the Middle East, Africa, and Latin
America; respiratory syndromes in North America
and Europe; and febrile systemic illness in Africa
and Oceania (Table 2). The distribution of single
etiological diagnoses differed significantly between
older and younger travelers, as shown in Table 3. Lower
respiratory tract infections (LRTIs), high-altitude
pulmonary edema (HAPE), arthropod bites, Plasmodium
falciparum severe malaria, rickettsiosis, gastritis, peptic
ulcer, esophagitis and gastroesophageal reflux disease
(GERD), strongyloïdes, trauma and injuries, altitude
illness, vertigo, cerebrovascular accident, urinary tract
infections (UTIs), heart disease, phlebitis, pulmonary
embolism, and death were more frequently observed
in older GeoSentinel patients compared to their
younger counterparts. Deaths in young and older
travelers were mainly caused by infectious diseases. In
contrast, acute bacterial and parasitic diarrhea, upper
respiratory tract infections (URTI), flu and flu-like
illnesses, larva migrans, dengue, non-severe P falciparum
and non-P falciparum malaria, salmonella infections,
genital infections and sexually transmitted diseases,
and schistosomiasis were comparatively less frequently
diagnosed in the older group. Illnesses observed in more
than 45 patients per age group were further investigated
Table 2 Syndrome groups according to age group and region of exposure (number of cases per 100 ill travelers) of 63,076 ill
travelers seen in GeoSentinel clinics between 1997 and 2008
All destinations Region of exposure (patients 60 y and over only)
Syndrome 18–45 y ≥60 y p-Value Asia
Australia/
New
Zealand Europe
Middle
East
North
America Africa Oceania
Latin
America p-Value
Number of patients 56,042 7,034 3,311 57 542 179 171 1,543 70 1,161
Acute diarrhea 22.9 16.7 <0.001 19.7 5.3 11.6 16.8 7.0 15.0 11.4 15.2 <0.001
Respiratory 10.3 14.6 <0.001 18.5 19.3 21.0 15.6 26.9 7.9 10.0 7.1 <0.001
Dermatologic 13.3 14.5 0.004 12.7 19.3 15.1 17.9 13.5 14.8 14.3 18.8 <0.001
Febrile systemic illness 18.3 12.6 <0.001 8.6 8.8 9.2 10.6 12.9 22.5 28.6 12.1 <0.001
Other gastrointestinal 6.1 7.6 <0.001 6.7 10.5 11.8 9.5 7.6 5.2 2.9 10.9 <0.001
Musculoskeletal 3.9 6.5 <0.001 9.9 12.3 6.8 1.7 7.0 2.4 1.4 2.9 <0.001
Chronic diarrhea 6.5 5.9 0.045 3.7 10.5 5.5 7.8 5.3 7.0 5.7 10.2 <0.001
Neurologic 2.2 3.6 <0.001 4.7 5.3 3.5 1.7 3.5 2.3 4.3 2.5 <0.001
GU and STD 2.8 3.5 0.001 4.5 1.8 5.4 0.6 3.5 2.9 – 1.6 <0.001
Chronic disease 1.8 3.4 <0.001 3.1 1.8 5.9 4.5 5.8 2.9 5.7 3.4 0.016
Cardiovascular 0.5 3.4 <0.001 4.2 7.0 6.8 0.6 7.6 1.4 1.4 2.1 <0.001
Psychological 2.1 1.5 0.001 1.4 5.3 2.2 1.1 3.5 1.2 4.3 1.4 0.021
Oral and dental 2.0 1.1 <0.001 1.6 – 0.9 1.1 1.2 0.6 – 0.5 0.018
Tissue parasite 0.9 1.0 0.34 0.4 – 0.6 0.6 – 2.9 1.4 0.7 <0.001
Ophthalmologic 0.6 0.7 0.33 1.2 – 0.4 1.1 – 0.1 0.0 0.3 <0.001
Obstetric/gynecologic∗ 2.3 0.3 <0.001 0.4 – – – – 0.1 – 0.7 0.61
–= no case; GU = genitourinary transmitted diseases; STD = sexually transmitted diseases.
∗Per 100 ill female patients.
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Table 3 Selected etiological diagnoses according to age
group (number of cases per 100 ill travelers) of 63,076 ill
travelers seen in GeoSentinel clinics between 1997 and 2008
Diagnosis (total number of cases) 18–45 y ≥60 y p Value
Number of patients 56,042 7,034
Acute diarrhea, bacterial (6,483) 11.2 7.3 <0.001
Acute diarrhea, parasitic (3,125) 5.4 3.5 <0.001
Upper respiratory tract infections
(4,106)
7.0 5.3 <0.001
Lower respiratory tract infections
(1,967)
2.8 7.3 <0.001
Influenza and flu-like illness (674) 1.2 0.8 0.003
High-altitude pulmonary edema
(271)
0.4 1.1 <0.001
Skin infections, bacterial (1,559) 2.6 2.7 0.60
Arthropod bite (1,428) 2.2 3.6 <0.001
Potentially rabid animal-related
injuries (1,099)
1.8 1.8 0.96
Larva migrans (669) 1.2 0.5 <0.001
Cutaneous and muco-cutaneous
leishmaniasis (253)
0.4 0.5 0.62
Myiasis (187) 0.3 0.3 0.72
Dengue (2,232) 4.0 1.4 <0.001
Plasmodium falciparum malaria—all
cases (1,567)
2.7 1.8 <0.001
Plasmodium falciparum
malaria—severe and complicated
(77)
0.1 0.3 <0.001
Non-P falciparum malaria (910) 1.6 0.9 <0.001
Salmonella infection (704) 1.3 0.5 <0.001
Rickettsial infection (272) 0.4 0.7 0.007
Chikungunya (135) 0.2 0.3 0.17
Gastritis, peptic ulcer, esophagitis,
and GERD (623)
1.0 1.6 <0.001
Viral hepatitis∗ (600) 1.0 1.1 0.27
Strongyloïdes (355) 0.5 1.1 <0.001
Trauma and injuries (1,311) 2.1 3.2 <0.001
Altitude illness (neurological)† (403) 0.6 1.2 <0.001
Meningitis and encephalitis (211) 0.3 0.4 0.19
Mefloquine intolerance (154) 0.3 0.2 0.89
Vertigo (104) 0.2 0.3 0.003
Cerebrovascular accident (40) 0.0 0.5 <0.001
Urinary tract infections (979) 1.6 2.2 <0.001
Genital infections and STD (748) 1.3 0.7 <0.001
Kidney stone (77) 0.1 0.2 0.14
Heart disease (147) 0.1 1.5 <0.001
Phlebitis and pulmonary embolism
(99)
0.1 0.4 <0.001
Schistosomiasis (580) 1.0 0.7 0.019
Death (39)‡ 0.0 0.2 <0.001
Vaccine side effects (12) 0.0 – 0.38
GERD = gastroesophageal reflux disease; STD = sexually transmitted disease.
∗Viral hepatitis: acute hepatitis A, B, C, and unspecified, chronic hepatitis B
and C, asymptomatic hepatitis B carrier, and hepatitis D and E (each type of
hepatitis was also compared separately between older and younger travelers and
no significant differences were evidenced).
†Altitude illness (neurological): high-altitude cerebral edema and acute mountain
sickness.
‡Death: 18–45 y (45 per 105): malaria (1), dengue (2), encephalitis (3),
angiostrongyloidiasis (1), rickettsial infection (2), Epstein Barr Virus (1),
respiratory infection (2), influenza (1), gastrointestinal infection (2), Salmonella
typhi (1), acquired immune-deficiency syndrome (1), trauma (4), cardiac (3), and
autoimmune disorder (1) and >60 y (199 per 105): malaria (3), pneumonia (4),
pneumococcal meningitis (1), pyelonephritis (2), gastrointestinal infection (1),
rabies (1), pulmonary embolism (1), and trauma (1).
Figure 1 Adjusted odds ratios (ORs) and 95% confidence
intervals (CIs) for diagnosis profiles for travelers aged 60
years and over versus travelers aged 18–45 years of 63,076
ill travelers seen in GeoSentinel clinics between 1997 and
2008. Only significant ORs are presented. Only diagnoses
including at least 45 cases by age group are presented.
Diagnosis profiles are adjusted for sex, reason for travel,
clinical settings, pre-travel advice, and region of exposure.
URTI = upper respiratory tract infection; LRTI = lower
respiratory tract infection; FLI = flu-like illness; HAPE =
high-altitude pulmonary edema; P falciparum malaria = all
cases including complicated malaria; G-PU-O = gastritis,
peptic ulcer, and esophagitis; GERD = gastroesophageal
reflux disease; UTI = urinary tract infection; GI = genital
infection; and STD = sexually transmitted disease. Heart
disease (OR 15.88, CI 11.17–22.87) was not included in the
figure due to the magnitude of the OR.
for potential confounders such as sex, reason for travel,
travel duration and region of travel, pre-travel advice,
clinical settings, and risk level qualifier. We found that
age per se was associated with the distinct patterns of
travel-associated illness observed in older and younger
individuals in all cases with the exception of high-
altitude cerebral edema, acute mountain sickness, and
strongyloïdes (Figure 1). Subanalysis in the older group
by age category showed a linear positive relationship
between age and the relative proportion of death, heart
disease, and LRTI, and an inverse relationship between
age and P falciparum malaria and dengue among ill
travelers, with all trends being significant (p < 0.001)
(Figure 2).
Discussion
Among ill adult travelers seen at GeoSentinel clinics,
individuals over 60 years of age represent a substantial
proportion of patients, and it is of significant interest
that 22% of older ill travelers in our cohort were
over 70 years of age. This suggests that the elderly
might represent an important proportion of individuals
seeking information on travel-related diseases and that
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Figure 2 Age dependence of selected travel-associated
diseases (number of cases per 100 ill travelers) of 63,076
ill travelers seen in GeoSentinel clinics between 1997 and
2008. LRTI = lower respiratory tract infection; P falciparum
malaria = all cases including complicated malaria. Only
significant trends are presented.
targeted pre-travel advice based on reliable data should
be provided. We observed that older ill travelers
returning to GeoSentinel sites conducted short-
term, pre-arranged, and organized tourism trips more
frequently, traveled more frequently to Europe and
the United States, and consequently sought pre-travel
advice less frequently than their younger counterparts.
This lower proportion who sought pre-travel advice
may also possibly reflect that they were more often
experienced travelers. While ideally all travelers should
be encouraged to receive a pre-travelmedical evaluation,
tour operators should particularly encourage this for
their older travelers, and should encourage this to occur
in a timely manner.
In our study, the spectrum of illness differed signif-
icantly based on the age of ill travelers after eliminating
confounding factors including travel destination. As
expected, the proportionate morbidity of age-associated
conditions was significantly higher in the older group.
This observation confirms that travel health advisors
or general practitioners who counsel older individu-
als at pre-travel consultations have to consider their
pre-travel health status and anticipate potential exac-
erbations, in particular by minimizing venous throm-
boembolism during travel through recommendation of
the use of anti-thrombosis compression stockings, suf-
ficient hydration and exercises during long-distance
flights, and by optimizing control of cardiovascular
diseases and referring at-risk patients to a cardiologist
for medical evaluation before departure.
Acute diarrhea was shown to be a comparatively
less frequent reason for presentation in older travelers
regardless of the responsible pathogen, and a lower
proportionate morbidity of diarrhea in older travelers
was found even after controlling for gender and travel
conditions (region, reason for travel, and pre-travel
advice). While this does not infer that the absolute
risk of acute diarrhea is lower in the elderly, other
studies support this finding.15,16 This may suggest
that the protection conferred by age is related to an
increased likelihood of past exposure to pathogens,17
or alternatively that there may be better adherence by
older individuals to reducing risky dietary exposures.18
No significant age-related difference in the proportion
of patients suffering from chronic diarrhea was observed
in our study.
While presenting comparatively less frequently with
URTI, older travelers had a greater proportionate
morbidity from LRTI, including pneumonia and bron-
chitis. This finding has been previously reported among
GeoSentinel patients.19 The GeoSentinel database do
not contain data on smokers or chronic obstructive
pulmonary disease (COPD); however, these factors
may have played a role as epidemiologically they are
more frequent in patients over the age of 60. Our
results suggest that older travelers should be targeted
for preventive measures against respiratory infections,
including handhygiene, use of disposable handkerchiefs,
and consideration of face-masks in crowded condi-
tions. Optimization of COPD management should
also be considered for older patients prior to travel.
Influenza was the most frequent vaccine-preventable
disease observed in our study. Although the proportion
of GeoSentinel patients who received an influenza vac-
cination is unknown, putative greater vaccination rates
in the elderly may have accounted for the higher pro-
portion of influenza observed among younger travelers.
This finding nevertheless supports the need for the vac-
cination of all travelers against influenza regardless of
age. Pneumococcal vaccines would also benefit older
travelers based on the higher proportion of individuals
>60 years of age that presented with LRTI.20
We observed that HAPE proportionate morbid-
ity was higher in older than younger ill travelers.
Also, the proportion of lower respiratory infections
in travelers suffering HAPE was only 12% in older
individuals and 17% in the younger group in our study.
While several earlier investigations in Nepal and else-
where concluded that older age might be protective
against altitude illness,21–23 recent studies challenge
these conclusions.24,25 We conclude that older travelers
to high-altitude destinations presented to GeoSentinel
clinics comparatively more frequently than younger
travelers, and that these data were not attributable
to concomitant respiratory infection. We propose that
older travelers have pre-travel cardiologic assessment
for high-altitude travel and strictly apply prevention
measures when undergoing a high-altitude trip by
progressive acclimatization to altitude and use of aceta-
zolamide.
While mosquito bites were more frequently reported
in older travelers, febrile, systemic mosquito-borne
illnesses like malaria and dengue were less frequent
reasons for presentation in older ill travelers. We have
no explanation for this paradoxical finding. Severe P
falciparum malaria, however, was comparatively more
J Travel Med 2012; 19: 169–177
 by guest on M
ay 9, 2016
http://jtm.oxfordjournals.org/
D
ow
nloaded from
 
Travel-Associated Illness in Older Adults 175
frequent in the older group, which has been observed
by others.26–28 As shown in a previous GeoSentinel
study, older age appeared to correlate with a higher
proportionate morbidity from rickettsial infections,
mainly due to spotted fever-group rickettsia.29 It has
been suggested that an increased likelihood of spotted
fever-group rickettsiae may be related to the increased
disposable income and leisure time required for African
safari itineraries.30 Although African tick-bite fever is
usually benign and self-limited, it may lead to more
severe complications in older travelers.31 Prevention
of arthropod bites using repellents and mosquito nets
and malaria chemoprophylaxis should be reinforced
regardless of age.
While the lower likelihood for older travelers
to present with cutaneous larva migrans and
schistosomiasis may not correlate with lower absolute
risks of these infections, it is nevertheless possible that
this finding results from a stronger adherence by older
individuals to avoiding contact with wet soil and fresh
water, thus less frequently engaging in at-risk activities.
Finally, the higher likelihood of travel-associated
UTI, gastritis, peptic ulcer, and GERD suggests that
these diseases should also be considered in older
travelers receiving pre-travel advice. Antibiotics for
the presumptive treatment of respiratory and UTIs
may be considered, as well as antacid medications
although the latter may possibly increase the risk of
traveler’s diarrhea.
We also found that the relative frequency of trauma
and injuries in travelers increased with advancing age,
which may result from age-related decreased sensory,
motor, and perceptual skills.
Deaths were four times more frequent in the older
group compared to the younger one and mainly caused
by infectious diseases which reflects the predominance
of specialized infectious diseases clinics in GeoSentinel
network, when deaths in travelers are usually caused by
trauma and non-communicable diseases.11
The major strength of our analysis is its multicenter
nature, which provided a large number of participants
from many countries and captured all traveler types, and
its focus on proportionate morbidity. The limitations
of this method of analysis have been recently
discussed.32 In particular, because the denominator
data (number of travelers) cannot be ascertained, it
is not possible to calculate incidence rates or absolute
risk. Also, this data might not be representative of
the overall population of travelers, and the results
do not represent the broad spectrum of illnesses
typically seen at non-specialized primary care practices
where mild or self-limited conditions present with
higher frequency. Due to the nature of GeoSentinel
clinics, illnesses acquired after travel to non-tropical
destinations or non-infectious travel-related illnesses
may be underrepresented. Underlying chronic diseases
are not documented by GeoSentinel which does not
allow evaluation of their influence on travel-associated
morbidity. However, the GeoSentinel database (and
associated analyses) has nevertheless been identified
as a valuable source of data on the epidemiology of
travel-related illnesses.13,32,33
In conclusion, older travelers represent a minority
of patients in travel clinics but they are usually sicker
with a higher relative proportion of life-threatening
diseases (LRTI, HAPE, severe P falciparum malaria,
cardiovascular disease, and pulmonary embolism),34 as
well as a higher proportion of death, compared to
younger patients. Older travelers should be specifically
targeted for the prevention of such diseases and
advised to obtain travel insurance that covers chronic
stable medical conditions, acute illnesses, accidents,
evacuation, and death.
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Appendix 1
Members of the GeoSentinel Surveillance Network
In addition to the authors, members of the GeoSentinel
Surveillance Network who contributed data (in
descending order) are as follows: Prativa Pandey,
CIWEC Clinic Travel Medicine Center, Kathmandu,
Nepal; Kevin C. Kain, University of Toronto,
Toronto, Canada; Gerd-Dieter Burchard, Bernhard-
Nocht-Institute for Tropical Medicine, Hamburg,
Germany; Michael D. Libman, Brian Ward, and J.
Dick Maclean, McGill University, Montreal, Canada;
AnneMcCarthy,University ofOttawa,Ottawa,Canada;
Bradley A. Connor, Cornell University, NewYorkCity,
New York, USA; Fabrice Simon and Jean Delmont,
Hoˆpital Nord, Marseille, France; Louis Loutan and
Franc¸ois Chappuis, University of Geneva, Geneva,
Switzerland; Vanessa Field, InterHealth, London,
United Kingdom; Andy Wang and Susan MacDonald,
Beijing United Family Hospital and Clinics, Beijing,
Peoples Republic of China; Mogens Jensenius, Oslo
University Hospital, Oslo, Norway; DeVon C. Hale
and Stephanie S. Gelman, University of Utah, Salt Lake
City, Utah, USA; Patricia Schlagenhauf, Rainer Weber,
and Robert Steffen, University of Zu¨rich, Zu¨rich,
Switzerland; Eric Caumes and Alice Pe´rignon, Hoˆpital
Pitie´-Salpeˆtrie`re, Paris, France; Nicole Anderson, Trish
Batchelor, and Dominique Meisch, International SOS
Clinic, Ho Chi Minh City, Vietnam; Giampiero
Carosi, University of Brescia, Brescia, Italy; William
M. Stauffer and Patricia F. Walker, University of
Minnesota, Minneapolis, Minnesota, USA; Annelies
Wilder-Smith, Tan Tock Seng Hospital, Singapore;
Carmelo Licitra and AntonioCrespo,OrlandoRegional
Health Center, Orlando, Florida, USA; Joseph Torresi
and Graham Brown, Royal Melbourne Hospital,
Melbourne, Australia; Natsuo Tachikawa, Hanako
Kurai, and Hiroko Sagara, Yokohama Municipal
Citizen’s Hospital, Yokohama, Japan; Christina M.
Coyle and Murray Wittner, Albert Einstein School
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of Medicine, New York City, New York, USA;
Phyllis E. Kozarsky and Carlos Franco-Paredes, Emory
University, Atlanta, Georgia, USA; Michael W. Lynch,
Fresno International Travel Medical Center, Fresno,
California, USA; N. Jean Haulman, David Roesel, and
Elaine C. Jong, University of Washington, Seattle,
Washington, USA; Sarah Borwein, Central Health
Medical Practice, Honk Kong SAR, China; Peter
J. de Vries and Kartini Gadroen, University of
Amsterdam, Amsterdam, The Netherlands; Thomas
B. Nutman and Amy D. Klion, National Institutes
of Health, Bethesda, Maryland, USA; Effrossyni
Gkrania-Klotsas, Addenbrooke’s Hospital, Cambridge,
United Kingdom; Lin H. Chen and Mary E.
Wilson, Mount Auburn Hospital and Harvard School
of Public Health, Harvard University, Cambridge,
Massachusetts, USA; Shuzo Kanagawa and Yasuyuki
Kato, International Medical Center of Japan, Tokyo,
Japan; David O. Freedman, University of Alabama at
Birmingham, Birmingham, Alabama, USA; Annemarie
Hern, Worldwise Travellers Health and Vaccination
Centre, Auckland, New Zealand; Vernon Ansdell,
Kaiser Permanente, Honolulu, Hawaii, USA; Alejandra
Gurtman, Mount Sinai Medical Center, New York
City, New York, USA (October 2002 to August
2005 only); Rogelio Lo´pez-Ve´lez and Jose Antonio
Perez Molina, Hospital Ramon y Cajal, Madrid,
Spain; Luis Valdez and Hugo Siu, Clinica Anglo
Americana, Lima, Peru; John D. Cahill and George
McKinley, St. Luke’s-Roosevelt Hospital Center, New
York City, New York, USA; Noreen Hynes, R.
Bradley Sack, and Robin McKenzie, Johns Hopkins
University, Baltimore, Maryland, USA; Cecilia Perret
and Francisca Valdivieso, Pontificia Universidad
Cato´lica de Chile, Santiago, Chile; Watcharapong
Piyaphanee and Udomsak Silachamroon, Mahidol
University, Bangkok, Thailand; Marc Mendelson and
Peter Vincent, University of Cape Town and Tokai
Medicross Travel Clinic, Cape Town, South Africa;
Robert Muller, Travel Clinic Services, Johannesburg,
South Africa (May 2004 to June 2005 only); Susan
McLellan, Tulane University, New Orleans, Louisiana,
USA (December 1999 to August 2005 only); Stefan
Hagmann and Andy O. Miller, Bronx-Lebanon
Hospital Center, New York City, New York, USA;
Robert Kass, Travellers Medical and Vaccination
Centres of Australia, Adelaide, Australia (December
1997 to March 2001 only); Patrick Doyle and Wayne
Ghesquiere, Vancouver General Hospital, Vancouver,
BritishColumbia, Canada; ElizabethD. Barnett, Boston
University, Boston, Massachusetts, USA; Paul Holtom,
Jeff Goad, and Anne Anglim, University of Southern
California, Los Angeles, California, USA; Nancy Piper
Jenks and Christine Kerr, Hudson River Health Care,
Peekskill, New York, USA; and Jose Flores-Figueroa
and Pablo C. Okhuysen, Travel Medicine Research
Clinic, Cuernavaca, Morelos, Mexico.
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